Pavel J.
- Country
- Czechia
- Department
- 2202: Hematologicko-onkologicke oddeleni
Research Overview
- Long-term Safety of Asciminib in Patients With Philadelphia Chromosome-Positive CML or ALL Continuing From Parent Studies
- Evaluation of Venetoclax and Azacitidine Combination Therapy Versus Placebo and Azacitidine in Treatment-Naïve Patients with Higher-Risk Myelodysplastic Syndrome
- Evaluation of Tolerability and Efficacy of Asciminib Hydrochloride Versus Nilotinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Data & Insights
Has run more than one trial at 154 of 298 partner sites.
Specializations
Myeloid Disorders
The investigator specializes in treating various myeloid conditions, with particular focus on acute myeloid leukemia and chronic myeloid leukemia. Their expertise extends to myelodysplastic syndrome, specifically addressing higher-risk cases.
- Primary and Secondary Myelofibrosis
- Post-Polycythemia Vera Myelofibrosis
- Post-Essential Thrombocythemia Myelofibrosis
The investigator works with innovative therapeutic approaches for these conditions, including targeted molecular therapies.
Lymphoid Malignancies
The investigator has extensive experience in treating lymphoid disorders, with particular emphasis on mantle cell lymphoma and diffuse large B-cell lymphoma.
- Follicular Lymphoma
- Chronic Lymphocytic Leukemia
- Waldenstrom Macroglobulinemia
- Marginal Zone Lymphoma
Their work involves combination therapy approaches and novel targeted treatments for these conditions.
Additional Oncological Focus
The investigator's expertise encompasses other oncological conditions requiring specialized therapeutic interventions.
- Multiple Myeloma
- Urothelial Carcinoma
- Breast Cancer
- Graft vs Host Disease
Their approach includes evaluating innovative treatment combinations and investigating novel therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.